Canada’s Federal Court of Appeal Limits Damages Available to Delayed Generics

June 08, 2009

Tags:

Food and Drug Regulatory Intellectual Property Intellectual Property Litigation Patents Pharmaceuticals

Related Expertise

Related Insights

Software as Medical Devices and Digital Health in Canada: What's Next?
Federal Court Addresses the Intention and Application of Vanessa's Law
Le gouvernement du Québec limite l'utilisation des programmes de fidélisation et de soutien aux patients dans un nouveau projet de règlement
Québec Government Limits use of Loyalty Cards and Patient Support in Draft Regulation
Phased Approach Announced for Proposed Changes to Self-Care Product Regulation

Back